Gubra A/S
CSE:GUBRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gubra A/S
CSE:GUBRA
|
DK |
|
P
|
Prominence Energy Ltd
SWB:RSX
|
AU |
|
F
|
FendX Technologies Inc
OTC:FDXTF
|
CA |
|
W
|
Wonik Cube Corp
KOSDAQ:014190
|
KR |
Intrinsic Value
Is GUBRA undervalued or overvalued?
See the intrinsic value estimate for Gubra A/S and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
GUBRA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with GUBRA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Gubra A/S Does
Gubra A/S is a Danish biotechnology company with two main businesses: it helps drug makers discover and test new medicines, and it develops its own peptide-based drug candidates. In its service business, Gubra works as a research partner for pharmaceutical and biotech companies, especially on metabolism, obesity, diabetes, and related disease areas. In its own pipeline, it focuses on finding and advancing treatments built around biologically active peptides.
- Headquarters
- Denmark DK
- Employees
- 300
- IPO date
- Apr 4, 2023
Earnings Waterfall
Gubra A/S
The intrinsic value for Gubra A/S (GUBRA) under the Base Case is hidden DKK.
Compared with the current market price of 295.8 DKK, the stock appears hidden.